首页 窥得儿医药(usQDEL)-基本信息

窥得儿医药(usQDEL)-基本信息

日报更新时间:

周报更新时间:04-11 03:39

行情信息

今开价:123.67

最高价:128.35

成交量:581998.0

昨收价:123.2

最低价:122.34

最新价:127.3

行情图标
概要信息

中文名称:窥得儿医药


英文名称:Quidel


行业:医疗


简介:Quidel Corporation是一家成立于特拉华州的企业


电话:1-858-5521100


最新量化综合结论
百科信息
  • 相关网站
  • 员工交易记录
  • 持股信息
  • 领导人信息

交易日期 交易人 职位 类型 交易份额 价格
2019-06-27 Bryant (Douglas C) Chief Executive Officer Sell 3461 60.06
2019-06-27 Bryant (Douglas C) Chief Executive Officer Buy 3461 15.19
2019-06-25 Bryant (Douglas C) Chief Executive Officer Buy 19412 15.19
2019-06-25 Bryant (Douglas C) Chief Executive Officer Buy 5838 12.63
2019-06-25 Bryant (Douglas C) Chief Executive Officer Sell 25250 57.25
2019-06-17 Russell (Edward Keith) Officer Buy 4197 15.40
2019-06-17 Russell (Edward Keith) Officer Buy 8803 18.32
2019-06-17 Russell (Edward Keith) Officer Sell 13000 57.16
2019-05-26 Kroll Werner Officer Buy 4377 --
2019-05-26 Kroll Werner Officer Sell 2170 54.42
2019-05-19 Slacik (Charles P) Director Sell 1000 55.19
2019-05-15 Buechler (Kenneth F) Director Buy 745 --
2019-05-15 Slacik (Charles P) Director Buy 222 --
2019-05-14 Slacik (Charles P) Director Buy 1661 --
2019-05-14 Schuler (Jack W) Director and Beneficial Owner Buy 1661 --
2019-05-14 Strobeck (Matthew W) Director Buy 1661 --
2019-05-14 Polan (Mary Lake Ph.D) Director Buy 1661 --
2019-05-14 Michael (Edward L) Director Buy 834 --
2019-05-14 Buechler (Kenneth F) Director Buy 1919 --
2019-05-14 Widder Kenneth Jon Director Buy 1661 --
2019-05-09 Buechler (Kenneth F) Director Sell 2002 60.58
2019-05-09 Buechler (Kenneth F) Director Buy 2002 11.96
2019-05-04 Polan (Mary Lake Ph.D) Director Buy 1756 --
2019-05-04 Polan (Mary Lake Ph.D) Director Buy 526 --
2019-04-15 Polan (Mary Lake Ph.D) Director Buy 7800 15.73

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Dimensional Fund Advisors LP 604846 1.52% -- -- 2019-07-31
Fred Alger Management Inc 1067910 2.68% -19482 -1.79% 2019-03-31
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 1138948 2.86% -194099 -14.56% 2019-03-31
BlackRock Fund Advisors 1161341 2.92% 5742 0.50% 2019-07-31
Oracle Investment Management Inc 1903558 4.78% -- -- 2019-03-31
BlackRock Inc 2288226 5.75% -16268 -0.71% 2019-03-31
Vanguard Group Inc 3201751 8.04% 162461 5.35% 2019-03-31
Brown Capital Management, LLC 5467982 13.73% -72242 -1.30% 2019-03-31
T. Rowe Price Associates, Inc. 6672209 16.76% 17373 0.26% 2019-03-31
Macquarie Group Ltd 1004395 2.52% 52544 5.52% 2019-03-31
Vanguard Investments Australia Ltd 940225 2.36% 11688 1.26% 2019-07-31
State Street Corporation 860895 2.16% 45931 5.64% 2019-03-31
Marshall Wace Asset Management Ltd 623440 1.57% 247006 65.62% 2019-03-31
Eagle Asset Management, Inc. 639841 1.61% 8939 1.42% 2019-03-31
Northern Trust Investments Inc 684176 1.72% 10087 1.50% 2019-07-31
T. Rowe Price 728906 1.83% 8680 1.21% 2019-07-31
Dimensional Fund Advisors, Inc. 749233 1.88% -111926 -13.00% 2019-03-31
New York State Common Retirement Fund 749998 1.88% 1700 0.23% 2019-03-31
Macquarie Investment Management 838805 2.11% 63240 8.15% 2019-07-31
Delaware Management Company 840485 2.11% 23212 2.84% 2019-07-31
BlackRock Asset Management Canada Ltd 796401 2.00% -114 -0.01% 2019-05-31
Geode Capital Management, LLC 775754 1.95% 415831 115.53% 2018-12-31
Gabelli Funds LLC 613000 1.55% -- -- 2018-12-31
FMG LLC 468099 1.19% 300 0.06% 2019-03-31
Gamco Investors, Inc. Et Al 505700 1.28% -2000 -0.39% 2018-12-31
OFI Global Asset Management, Inc. 732619 1.86% 44484 6.46% 2018-12-31
OppenheimerFunds Inc 901814 2.29% -204 -0.02% 2018-09-30
Delaware Management Business Trust 830139 2.11% -272476 -24.71% 2018-06-30
BlackRock Institutional Trust Company NA 918266 2.33% 109093 13.48% 2018-06-30
Millennium Management LLC 555948 1.41% -440867 -44.23% 2018-06-30
State Street Corp 726889 1.86% 90126 14.15% 2018-06-30
Renaissance Technologies Corp 507687 1.30% -66413 -11.57% 2018-06-30
Northern Trust Investments N A 424383 1.09% 57813 15.77% 2018-06-30
D. E. Shaw & Co LP 394586 1.01% -23477 -5.62% 2018-06-30
Cannell Peter B & CO Inc 354800 0.91% -500 -0.14% 2018-06-30
Rothschild Asset Management Inc 382565 0.98% 382565 -- 2018-06-30
MFS Investment Management KK 333652 0.86% 60651 22.22% 2018-06-30
Goldman Sachs Asset Management LP 790776 2.11% -14561 -1.81% 2018-03-31
Point72 Asset Management, L.P. 636764 1.70% 370763 139.38% 2018-03-31
NORGES BANK 573538 1.66% -203168 -26.16% 2017-12-31
Marshall Wace North America LP 474884 1.40% 303084 176.42% 2017-09-30
Macquarie Investment Management Limited 1004662 2.96% 1004662 -- 2017-09-30
Wellington Management Company LLP 390323 1.15% 390323 -- 2017-09-30
Test Hedge Fund Mgmt 397770 1.17% 397770 -- 2017-09-30
Janus Capital Management LLC 2073696 6.30% -743998 -26.40% 2016-12-31
J.P. Morgan Investment Management Inc 593850 1.82% -217000 -26.76% 2016-09-30
Arrowpoint Asset Management, LLC 1093455 3.35% -194095 -15.07% 2016-09-30
Vanguard Group 1796645 3.00% 44682561 -- 1999-11-30
Entities affiliated with Larry N. Feinberg 2911133 3.00% 72399878 0.10% 1999-11-30
Wellington Management Group, LLP 3244157 3.00% 80682185 0.10% 1999-11-30
Jack W. Schuler 5339671 3.00% 132797618 0.20% 1999-11-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
iShares Russell 2000 Growth ETF 324973 0.82% 4109 1.28% 2019-07-30
Delaware Sm-Cap Core Eq-UBS 838805 2.11% 63240 8.15% 2019-06-30
T. Rowe Price Health Sciences Fund 849533 2.13% -5500 -0.64% 2019-06-30
Vanguard Small Cap Index 912749 2.29% 37534 4.29% 2019-06-30
Vanguard Total Stock Market Index Fund 931567 2.34% 10389 1.13% 2019-06-30
T. Rowe Price Small-Cap Stock Fund 993500 2.50% -6300 -0.63% 2019-06-30
T. Rowe Price New Horizons Fund 1033468 2.60% -3300 -0.32% 2019-06-30
T. Rowe Price Small-Cap Value Fund 1461606 3.67% -107000 -6.82% 2019-06-30
Brown Capital Management Small CompanyFd 2835704 7.12% 143497 5.33% 2019-06-30
Delaware Small Cap Core Fund 838805 2.11% 23322 2.86% 2019-06-30
Alger Small Cap Focus Fund 836020 2.10% 210137 33.57% 2019-05-31
iShares Russell 2000 ETF 772606 1.94% 1507 0.20% 2019-07-30
T. Rowe Price U.S. Small-Cap Value Eq Tr 351082 0.88% -11400 -3.14% 2019-06-30
Carillon Eagle Small Cap Growth Fund 397803 1.00% -- -- 2019-06-30
1290 VT GAMCO Small Company Value Port 446000 1.12% -- -- 2019-05-31
Vanguard Extended Market Index Fund 489530 1.23% 772 0.16% 2019-06-30
Gabelli Small Cap Growth Fund 505000 1.27% -69000 -12.02% 2019-03-31
Vanguard Small Cap Growth Index Fund 524853 1.32% 28200 5.68% 2019-06-30
T. Rowe Price US SmCp Core Equity Tr 527486 1.32% 15000 2.93% 2019-06-30
T. Rowe Price Instl Small-Cap Stock Fund 527486 1.32% 15000 2.93% 2019-06-30
DFA US Small Cap Portfolio 282609 0.71% -- -- 2019-04-30
iShares US Small Cap ETF (CAD-Hedged) 696747 1.75% -1170 -0.17% 2019-05-30
Vanguard Small Cap Index Fund 876420 2.20% 6142 0.71% 2019-04-30
Vanguard Explorer Fund 282636 0.71% 282636 -- 2018-12-31
Meridian Growth Fund 259457 0.65% 259457 -- 2018-12-31
Columbia Small Cap Growth Fund I 242900 0.62% 26100 12.04% 2019-02-28
T. Rowe Price US Smaller Companies Eq Fd 239265 0.61% 4105 1.75% 2018-12-31
Nationwide Small Company Growth Fund 191341 0.49% -- -- 2018-12-31
MFS New Discovery Fund 228073 0.58% 28127 14.07% 2018-11-30
Oppenheimer Discovery Fund 469740 1.19% 40660 9.48% 2018-11-30
Goldman Sachs Small Cap Value Fund 512946 1.30% -12251 -2.33% 2018-03-31
MFS 199946 0.51% -- -- 2018-10-31
Alger Small Cap Focus A 648582 1.66% 34865 5.68% 2018-06-30
DFA US Micro Cap I 182774 0.47% -13600 -6.93% 2018-07-31
SPDR 171589 0.42% 998 0.59% 2018-09-13
Nationwide Small Company Growth A 191341 0.49% -- -- 2018-07-31
MFS New Discovery A 199946 0.51% -- -- 2018-07-31
DFA US Small Cap I 252545 0.65% -- -- 2018-07-31
Brown Capital Mgmt Small Co Inv 2521626 6.47% 1224 0.05% 2018-06-30
T. Rowe Price Small-Cap Value 1681000 4.31% -11000 -0.65% 2018-06-30
T. Rowe Price Health Sciences 913533 2.34% 115600 14.49% 2018-06-30
T. Rowe Price Small-Cap Stock 911900 2.34% 911900 -- 2018-06-30
Vanguard Total Stock Mkt Idx 799818 2.05% 920 0.12% 2018-07-31
Delaware Small Cap Core A 622000 1.59% 18900 3.13% 2018-07-31
Gabelli Small Cap Growth AAA 578000 1.48% -12000 -2.03% 2018-06-30
EQ/GAMCO Small Company Value IB 460000 1.18% -25000 -5.15% 2018-07-31
iShares Russell 2000 Growth 317236 0.77% -306 -0.10% 2018-09-12
Vanguard Extended Market Idx Inv 426900 1.09% 3200 0.76% 2018-07-31
T. Rowe Price Instl Small-Cap Stock 439800 1.13% 439800 -- 2018-06-30
Oppenheimer Discovery A 432540 1.11% 33060 8.28% 2018-07-31
Vanguard Small Cap Growth Index Inv 457415 1.17% 6813 1.51% 2018-07-31
Oppenheimer Main Street Small Cap VA Svc 181270 0.46% -33610 -15.64% 2018-07-31
Fidelity Spartan 142157 0.38% 13550 10.54% 2018-05-31
Goldman Sachs Small Cap Value A 512946 1.37% -12251 -2.33% 2018-03-31
Alger Small Cap Growth Institutional I 151885 0.41% -2177 -1.41% 2018-04-30
Alger Small Cap Growth I-2 156425 0.42% -2084 -1.31% 2018-03-31
Northwestern Mutual Ser Small Cap Value 138800 0.37% -4300 -3.00% 2018-03-31
Loomis Sayles Small Cap Value Instl 139565 0.40% -- -- 2018-01-31
TETON Westwood Mighty Mites AAA 147061 0.43% -- -- 2017-12-31
Janus Triton D 1317098 4.03% -20605 -1.54% 2016-12-31
Janus Venture D 506048 1.55% -143201 -22.06% 2016-12-31
Meridian Growth Legacy 298579 0.91% -- -- 2016-12-31
Vanguard Explorer Inv 278908 0.85% -62647 -18.34% 2016-09-30
JPMorgan US Small Company Instl 284200 0.87% 7000 2.53% 2016-12-31
JPMorgan Small Cap Value A 188000 0.58% -- -- 2016-12-31
Janus Triton Fund 1706087 5.10% -- -- 2015-09-30
Janus Venture Fund 714395 2.10% -- -- 2015-09-30
EQ/GAMCO Small Company Value 548000 1.60% -- -- 2015-09-30
iShares Russell 2000 (AU) 458601 1.50% -576 -0.10% 2015-11-19
Meridian Growth Fund® 416478 1.20% 27159 7.00% 2015-09-30
Loomis Sayles Small Cap Growth Fund 314772 0.90% 572 0.20% 2015-09-30
JPMorgan Small Cap Value 314303 0.90% 133503 73.80% 2015-09-30
Brown Capital Management Small Company 2508452 7.50% -- -- 2015-10-31

Jack W. Schuler Founder of Crabtree Partners LLC, Jack W. Schuler is on the board of Quidel Corp., Accelerate Diagnostics, Inc. and Biodesix, Inc. and Partner at Crabtree Partners LLC. In his past career Mr. Schuler held the position of Lead Independent Director at Stericycle, Inc., President & Chief Operating Officer for Abbott Laboratories and Chairman at Ventana Medical Systems, Inc. Mr. Schuler received an undergraduate degree from Tufts University and an MBA from Stanford Graduate School of Business.
Randall J. Steward Presently, Randall J. Steward occupies the position of Chief Financial Officer of Quidel Corp. He is also Member of The American Institute of Certified Public Accountants. In the past Mr. Steward held the position of Chief Operating Officer at SeQual Technologies, Inc., Chief Financial Officer for Navilyst Medical, Inc., Chief Financial Officer & Executive Vice President of Spectrum Brands, Inc. and Independent Consultant at Thermoscan, Inc. Mr. Steward received an undergraduate degree from Southern Methodist University.
Kenneth J. Widder Founder of Santarus, Inc., Molecular Biosystems, Inc., FeRx, Inc. and NovaCardia, Inc., Kenneth J. Widder is an entrepreneur and businessperson who has been at the head of 6 different companies and currently holds the position of Executive Chairman for OrphoMed, Inc. and Partner at Latterell Venture Partners. Dr. Widder is also on the board of 7 other companies. In his past career he was Chairman & Chief Executive Officer of Converge Medical, Inc., Managing Member at Windamere Venture Partners LLC, Chairman & Chief Executive Officer at Molecular Biosystems, Inc., Chairman at Sytera, Inc., Chairman for Santarus, Inc. and Chief Executive Officer at NovaCardia, Inc. Dr. Widder received an undergraduate degree from Carleton College and a graduate degree from Northwestern University.
Karen S. Gibson Karen S. Gibson is VP, Information Services & Integration Lead at Quidel Corp. In her past career she occupied the position of Chief Information Officer & Senior Vice President of Invitrogen Corp., Chief Information Officer & Senior Vice President at US Oncology, Inc., Director-Information Technology at Accredo Health Group, Inc., Chief Information Officer & VP-Global eBusiness at GE Medical Systems Cesk�0�1�0�3 Republika sro, Chief Information Officer & Vice President at GE Healthcare IT, Chief Information Officer & Senior Vice President for McKesson Specialty Health, Inc., Chief Information Officer & Senior Vice President of Life Technologies, Inc. and Information Management Leader at General Electric Industrial Control Systems. She received an undergraduate degree from Purdue University and an MBA from The Ohio University.
Thomas D. Brown Thomas D. Brown is on the board of Quidel Corp., Accelerate Diagnostics, Inc. and Stericycle, Inc. Mr. Brown previously occupied the position of President-Diagnostics Division & Senior VP at Abbott Laboratories. Mr. Brown received an undergraduate degree from State University of New York at Buffalo.
Werner Kroll Currently, Werner Kroll occupies the position of Senior Vice President-Research & Development at Quidel Corp. Dr. Kroll is also on the board of European Personalised Medicine Association. In his past career Dr. Kroll was VP & Head-Research & Innovation at Novartis Institutes for Biomedical Research, Inc. He received a doctorate from Philipps University of Marburg.
Michael Donald Abney Michael Donald Abney is Senior Vice President-Distribution at Quidel Corp. In the past he occupied the position of Vice President-Supplier Management at PSS World Medical, Inc. and Vice President-Channel & Distribution at ConvaTec, Inc. Mr. Abney received an undergraduate degree from the University of Florida and an undergraduate degree from the University of Florida.
Charles P. Slacik Charles P. Slacik is on the board of Quidel Corp. and Member of Financial Executives International - Orange County and Member of The Connecticut Society of Certified Public Accountants. In the past Mr. Slacik held the position of Chief Financial Officer & Executive Vice President at Actavis, Inc., Chief Financial Officer & Senior Vice President at Beckman Coulter, Inc. and Chief Financial Officer & Senior Vice President of C.R. Bard, Inc. (New Jersey). Mr. Slacik received an undergraduate degree from the University of Connecticut.
Kenneth F. Buechler Founder of Alere San Diego, Inc. and Biosite, Inc. (Massachusetts), Kenneth F. Buechler presently is Chairman for Quidel Corp. He is also on the board of Sotera Wireless, Inc., Astute Medical, Inc. and Edico Genome Corp. and Member of American Association for Clinical Chemistry, Member of Biochemical Society, Member of International Federation of Clinical Chemistry & Lab Medicine and Member of American Chemical Society. Kenneth F. Buechler previously occupied the position of Chairman of Sequenom, Inc., President, Director & Chief Scientific Officer at Biosite, Inc. (Massachusetts), President & Chief Scientific Officer at Alere San Diego, Inc. and Senior Scientist at Hybritech, Inc. Kenneth F. Buechler received an undergraduate degree and a doctorate from Indiana University.
Mary Lake Polan Mary Lake Polan is Professor at Yale School of Medicine and Member of Institute of Medicine and on the board of 8 other companies. She previously occupied the position of Managing Director at Golden Seeds, Inc. and Professor at Stanford University School of Medicine. She received an undergraduate degree from Connecticut College, a graduate degree from the University of California, Berkeley, a doctorate from Yale School of Medicine and a doctorate from Yale University.
Matthew William Strobeck Founder of Birchview Capital LP, Matthew William Strobeck currently is Chief Investment Officer & Managing Partner at this company. Dr. Strobeck is also on the board of 6 other companies. In the past Dr. Strobeck was Consultant at Thomas Weisel Asset Management LLC and Partner at Westfield Capital Management Co. LP. He received a doctorate from the University of Cincinnati (Ohio), an undergraduate degree from St. Lawrence University, a graduate degree from Harvard University and a graduate degree from MIT Sloan School of Management.
Douglas C. Bryant Douglas C. Bryant holds the position of President, Chief Executive Officer & Director at Quidel Corp. Mr. Bryant previously was Chief Operating Officer & Executive Vice President of Luminex Corp. and VP-Molecular Global Commercial Operations at Abbott Laboratories Vice President-Asia & Japan at Abbott Vascular Devices and Vice President-Global Commercial Operations at Abbott Diagnostics, Inc. (both are subsidiaries of Abbott Laboratories). Douglas C. Bryant received an undergraduate degree from the University of California, Davis.
Edward L. Michael Edward L. Michael occupies the position of Executive Partner at Tyree & D'Angelo Partners LLC. He is also on the board of 6 other companies. He previously occupied the position of Executive Vice President-Diagnostics Products at Abbott Laboratories Senior Vice President-Medical Products at Abbott Molecular, Inc. and Vice President-Immunoassay & Clinical Chemistry at Abbott Diagnostics, Inc. (both are subsidiaries of Abbott Laboratories), Senior Vice President-Medical Products at Abbott Spine, Inc. and Senior Vice President-Medical Products at Abbott Animal Health, Inc. Mr. Michael received an undergraduate degree and a graduate degree from Indiana University.
Kathy P. Ordo�0�1±ez Kathy P. Ordo�0�1±ez is a businessperson who founded Celera Diagnostics LLC and who has been the head of 6 different companies. She is on the board of Quidel Corp., Pacific Biosciences of California, Inc. and Advanced Medical Technology Association. In the past Ms. Ordo�0�1±ez held the position of President of Celera Diagnostics LLC, Senior Vice President-Diagnostic Solutions at Quest Diagnostics, Inc. President & Chief Executive Officer at Celera Corp. and President of Celera Group (both are subsidiaries of Quest Diagnostics, Inc.), Non-Executive Chairman & Chief Executive Officer at RainDance Technologies, Inc., President & Chief Executive Officer for Roche Molecular Systems, Inc., President at Roche Diagnostics Corp., Principal at Hoffmann-La Roche, Inc. and Senior Vice President at Applera Corp. She received an MBA from Pace University and an undergraduate degree from Hartwick College.
Robert Joseph Bujarski Presently, Robert Joseph Bujarski occupies the position of Senior Vice President & General Counsel at Quidel Corp. He previously held the position of Associate Attorney at Gibson, Dunn & Crutcher LLP. He received an undergraduate degree and a graduate degree from the University of Arizona.
William J. Ferenczy William J. Ferenczy is Vice President Strategy at Quidel Corp. He previously held the position of Principal at General Medical Corp., Principal at Abbott Laboratories and Vice President-Marketing at Alere San Diego, Inc. (a subsidiary of Abbott Laboratories) and Vice President-Sales & Marketing of Inovise Medical, Inc. Mr. Ferenczy received an undergraduate degree from the University of Notre Dame.
Ruben Argueta Presently, Ruben Argueta occupies the position of Media & Investor Relations Contact at Quidel Corp.
Edward Kieth Russell Edward Kieth Russell is Senior Vice President-Global Commercial Operations at Quidel Corp. In his past career Mr. Russell occupied the position of President & General Manager at Life Technologies Japan Ltd. and General Manager-Global Services & Support Division at Life Technologies, Inc. Mr. Russell received an undergraduate degree from US Coast Guard Academy and an MBA from The Wharton School of the University of Pennsylvania.
Ratan S. Borkar Ratan S. Borkar is Senior VP-International Commercial Operations at Quidel Corp. Mr. Borkar received an MBA from Stephen M. Ross School of Business and an undergraduate degree from the University of Mumbai.
Edward L. Michael Edward L. Michael occupies the position of Executive Partner at Tyree & D'Angelo Partners LLC. He is also on the board of 6 other companies. He previously occupied the position of Executive Vice President-Diagnostics Products at Abbott Laboratories Senior Vice President-Medical Products at Abbott Molecular, Inc. and Vice President-Immunoassay & Clinical Chemistry at Abbott Diagnostics, Inc. (both are subsidiaries of Abbott Laboratories), Senior Vice President-Medical Products at Abbott Spine, Inc. and Senior Vice President-Medical Products at Abbott Animal Health, Inc. Mr. Michael received an undergraduate degree and a graduate degree from Indiana University.
Phillip Askim Presently, Phillip Askim holds the position of Secretary at Quidel Corp.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐